Duodopa 20 mg/ml + 5 mg/ml intestinalni gel
| Name | Duodopa 20 mg/ml + 5 mg/ml intestinalni gel |
|---|---|
| Marketing Authorisation Number | HR-H-753613005 |
| Active Substance | levodopa karbidopa hidrat |
| Composition | 1 ml gela sadrži 20 mg levodope i 5 mg karbidope hidrata |
| Pharmaceutical Form | intestinalni gel |
| Packaging [MA Number for Packaging] | 100 ml gela u vrećici u kazeti, sedam kazeta u kutiji [HR-H-753613005-01] |
| Manufacturer | Fresenius Kabi Norge AS, Halden, Norveška AbbVie Logistics B.V., JV Zwolle, Nizozemska |
| Marketing Authorisation Holder | AbbVie d.o.o., Strojarska cesta 20, Zagreb, Hrvatska |
| Marketing Authorisation Date | 30.05.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/307 |
| Registration Number | 381-12-01/70-19-03 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N04BA02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Kratke upute za zdravstvene radnike, verzija 2 Kratke upute za kontrolni posjet, verzija 2 Upute za zdravstvene radnike o primjeni lijeka, verzija 2 Upute za zdravstvene radnike o ciljanim aspektima, verzija 2 |
| Educational materials for patients / caregivers |
Priručnik za bolesnike, verzija 3 |
